Top Picks For Dec: DRChoksey Lists 6 Stocks With Double-Digit Upside; HDFC AMC, TCS & More — Check Full List

DRChoksey recommends a six-month investment period for these picks, citing strong earnings visibility and sectoral tailwinds.

Investors seeking a balanced portfolio exposure across cement, FMCG, IT, banking, asset management, and pharma may find DRChoksey's ideas attractive for December. (photo source: Envato)

As 2025 draws to a close, Deven Choksey Research has unveiled its InvestPro Top Idea Picks for December, spotlighting six high-conviction stocks across diverse sectors. These recommendations are backed by strong fundamentals, resilient business models, and promising growth trajectories, offering investors potential upsides ranging from 13.9% to 25.6% over the next six months.

NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

DRChoksey Report

Top Stock Picks for December: DRChoksey’s High-Conviction Ideas with Up to 25% Upside.

HDFC AMC Ltd – Target Rs 3,319 (Upside: 25.6%)

DRChoksey reiterates 'Buy' rating HDFC Asset Management Company Ltd. on the stock, led by its improving market share and disciplined cost management. The management's strategic emphasis on innovation and talent alignment further strengthens its long-term competitive positioning.

At a valuation of 40x Jun’27 EPS, the stock offers the highest potential upside among the December picks at 25.6%.

Alembic Pharma – Target Rs 1,132 (Upside: 25.4%)

Alembic Pharmaceutical Ltd. is expected to maintain steady growth momentum supported by its expanding complex generics portfolio in the US, sustained traction in Ex-US markets, and a gradual recovery in the domestic formulations business.

Margin improvement is likely to continue, driven by higher plant utilization, operational efficiency, and a favorable product mix. The company’s consistent R&D investments and prudent cost management are expected to strengthen its earnings visibility and enhance return ratios over the medium term.

TCS – Target Rs 3,615 (Upside: 15.3%)

Headcount optimization, stable attrition, and wage normalization supported margins in Q2. Combined with strong deal momentum and AI-led transformation investments, these factors are expected to drive margin resilience and revenue acceleration in H2 FY26. Looking ahead, Tata Consultancy Services Ltd.’s medium-term performance will depend on its ability to scale AI- and cloud-driven transformation programs amid a cautious global IT spending environment.

While enterprise adoption of AI and digital modernization provides a strong structural growth tailwind, tight discretionary budgets and the potential for AI-led automation to compress legacy service revenues remain key risks to monitor.

Click on the attachment to read the full report:

Deven Choksey Research InvestPro_Top Idea Picks December.pdf
Read Document

Also Read: Time Technoplast: Motilal Oswal Projects 44% Upside, Maintains 'Buy' On Attractive Valuation

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

lock-gif
To continue reading this story You must be an existing Premium User
Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit. Feel free to Add NDTV Profit as trusted source on Google.
GET REGULAR UPDATES
Add us to your Preferences
Set as your preferred source on Google